References

Severe oral mucositis after intensity-modulated radiation therapy for head and neck cancer.

10.1001/jamanetworkopen.2023.37265 · 2023 · External reference

Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline.

10.1200/jco.22.02198 · 2023 · External reference

The stigma surrounding opioid use as a barrier to cancer-pain management: an overview of experiences with fear, shame, and poorly controlled pain in the context of advanced cancer.

10.3390/curroncol30060437 · 2023 · External reference

Risk of chronic opioid use after radiation for head and neck cancer: a systematic review and meta-analysis.

10.1016/j.adro.2020.09.023 · 2020 · External reference

Implications of treatment modality on chronic opioid use following treatment for head and neck cancer.

10.1177/0194599820960137 · 2021 · External reference

Long-term opioid use in patients treated with head and neck intensity-modulated radiotherapy.

10.1007/s00520-022-07155-7 · 2022 · External reference

Long-term opioid use after treatment of head and neck cancers: a systematic review and meta-analysis.

10.1002/ohn.70024 · 2026 · External reference

Long-term opioid use in curative-intent radiotherapy: one-year outcomes in head/neck cancer patients.

10.1002/hed.26034 · 2020 · External reference

Opioid prescribing patterns for head and neck cancer radiation patients, with a comparison to breast cancer radiation patients.

10.1200/jco.2023.41.16_suppl.e18051 · 2023 · External reference

Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.

10.1038/bjp.2008.100 · 2008 · External reference

Predictors of long-term opioid treatment among patients who receive chemoradiation for head and neck cancer.

10.1634/theoncologist.2013-0001 · 2013 · External reference

Preexisting psychiatric risk factors and any and long-term opioid use in head and neck cancer.

10.1001/jamaoto.2025.2649 · 2025 · External reference

Chronic opioid use following surgery for oral cavity cancer.

10.1001/jamaoto.2017.0582 · 2017 · External reference

Risk of prolonged opioid use among cancer patients undergoing curative intent radiation therapy for head and neck malignancies.

10.1016/j.oraloncology.2019.03.007 · 2019 · External reference

Chronic opioid use in patients undergoing treatment for oropharyngeal cancer.

10.1002/lary.27791 · 2019 · External reference

Predictors of chronic opioid use: a population-level analysis of North Carolina cancer survivors using multi-payer claims.

10.1093/jnci/djab082 · 2021 · External reference

Associations between cancer-related financial hardship, pain, and opioid use.

10.1200/op-25-00683 · 2026 · External reference

Referral patterns of outpatient palliative care among the head and neck cancer population.

10.1055/s-0041-1741436 · 2022 · External reference

Predicting persistent opioid use, abuse, and toxicity among cancer survivors.

10.1093/jnci/djz200 · 2020 · External reference

Validation of an oncology-specific opioid risk calculator in cancer survivors.

10.1002/cncr.33410 · 2021 · External reference

Opioid Therapy vs. Multimodal Analgesia in Head and Neck Cancer (OPTIMAL-HN): results of a randomized clinical trial.

10.1016/j.radonc.2025.110831 · 2025 · External reference

A single-institution, randomized, pilot study evaluating the efficacy of gabapentin and methadone for patients undergoing chemoradiation for head and neck squamous cell cancer.

10.1002/cncr.32676 · 2020 · External reference

Association of gabapentin use with pain control and feeding tube placement among patients with head and neck cancer receiving chemoradiotherapy.

10.1001/jamanetworkopen.2022.12900 · 2022 · External reference

Prophylactic high-dose gabapentin reduces opiate use during radiation therapy for head and neck squamous cell carcinoma.

10.3390/cancers15072003 · 2023 · External reference

A pharmacist-led opioid de-escalation program after completion of chemoradiotherapy in locally advanced head and neck cancer.

10.3389/fonc.2023.1145323 · 2023 · External reference

Clinical pharmacists and nurses in the management of oral mucositis in head and neck cancer patients during antineoplastic therapy: a scoping review.

10.1177/20503121251339581 · 2025 · External reference

E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.

10.1200/jco.2016.68.3300 · 2017 · External reference

Induction nivolumab before chemoradiation in high-risk human papillomavirus-driven oropharynx cancers: IMMUNEBOOST-HPV, a multicenter randomized phase II trial.

10.1200/jco-25-00835 · 2026 · External reference

Clinical relevance of immune checkpoint inhibitors for the analgesic effect of opioids: a retrospective propensity score analysis.

10.1111/bcp.16377 · 2025 · External reference

Prevalence of opioid misuse in patients with cancer: a systematic review and meta-analysis.

10.1038/s41416-024-02802-8 · 2024 · External reference

National patterns in prescription opioid use and misuse among cancer survivors in the United States.

10.1001/jamanetworkopen.2020.13605 · 2020 · External reference

Comorbid depression in patients with head and neck cancer compared with other cancers.

10.1001/jamaoto.2024.3233 · 2024 · External reference

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons With Harmful Alcohol Consumption–II.

10.1111/j.1360-0443.1993.tb02093.x · 1993 · External reference

Financial toxicity on treatment outcomes in head and neck cancer patients undergoing radiation therapy.

10.1186/s13014-025-02749-x · 2025 · External reference

Patterns of alcohol use among early head and neck cancer survivors: a cross-sectional survey study using the Alcohol Use Disorders Identification Test (AUDIT).

10.1016/j.oraloncology.2021.105328 · 2021 · External reference

Unresolved reference

External reference

Unresolved reference

External reference